Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE21-006: Rigorously Evaluating Programs and Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Meeting, 32934 [2021-13121]
Download as PDF
<![CDATA[
32934
Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices
vaccine, dengue vaccine, ebola vaccine,
hepatitis vaccines, herpes zoster
vaccines, influenza vaccines,
orthopoxvirus vaccine, pneumococcal
vaccine, rabies vaccine and tickborne
encephalitis vaccine. Recommendation
votes on dengue vaccine, ebola vaccine,
influenza vaccines and rabies vaccine
are scheduled. Vaccines for Children
(VFC) votes on dengue vaccine and
influenza vaccines are scheduled.
Agenda items are subject to change as
priorities dictate. For more information
on the meeting agenda visit https://
www.cdc.gov/vaccines/acip/meetings/
meetings-info.html.
Meeting Information: The meeting
will be webcast live via the World Wide
Web; for more information on ACIP
please visit the ACIP website: https://
www.cdc.gov/vaccines/acip/.
jbell on DSKJLSW7X2PROD with NOTICES
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment. Oral
public comment will occur before any
scheduled votes including all votes
relevant to the ACIP’s Affordable Care
Act and Vaccines for Children Program
roles. Priority will be given to
individuals who submit a request to
make an oral public comment before the
meeting according to the procedures
below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the June 23–25,
2021, ACIP meeting must submit a
request at https://www.cdc.gov/vaccines/
acip/meetings/ no later than 11:59 p.m.,
VerDate Sep<11>2014
17:13 Jun 22, 2021
Jkt 253001
EDT, June 18, 2021, according to the
instructions provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by June 21, 2021. To accommodate the
significant interest in participation in
the oral public comment session of
ACIP meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
Written Public Comment: The docket
will be opened to receive written
comments on June 1, 2021. Written
comments must be received on or before
June 25, 2021.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–13120 Filed 6–22–21; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—CE21–006:
Rigorously Evaluating Programs and
Policies To Prevent Child Sexual
Abuse (CSA); Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—CE21–
006: Rigorously Evaluating Programs
and Policies to Prevent Child Sexual
Abuse (CSA); July 13–14, 2021, 8:30
a.m.–5:00 p.m., EDT.
The videoconference meeting was
published in the Federal Register on
March 29, 2021, Volume 86, Number 58,
page 16369.
The meeting is being amended to
update the contact person and should
read as follows:
Frm 00053
Fmt 4703
Aisha Wilkes, M.P.H., Scientific Review
Officer, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop S106–9,
Atlanta, Georgia 30341, Telephone:
(404) 639–6473; Email: awilkes@
cdc.gov.
The meeting is closed to the public.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–13121 Filed 6–22–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
BILLING CODE 4163–18–P
PO 00000
FOR FURTHER INFORMATION CONTACT:
Sfmt 4703
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control (BSC, NCIPC). This meeting
is partially open to the public. There
will be 15 minutes allotted for public
comments at the end of the open session
from 11:40 a.m., to 11:55 p.m., EDT.
DATES: The meeting will be held on July
29, 2021, from 10:00 a.m. to 12:00 p.m.,
EDT (OPEN); and from 12:30 p.m., to
4:15 p.m., EDT (CLOSED).
ADDRESSES: Open Session: Webinar,
Atlanta, Georgia. All participants must
register using the link provided to
attend the open meeting: https://
dceproductions.zoom.us/webinar/
register/wn_cz3nu0zfsg29fiojefau8q.
Closed Session: Teleconference.
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop S106–9, Atlanta,
SUMMARY:
E:\FR\FM\23JNN1.SGM
23JNN1
]]>Agencies
[Federal Register Volume 86, Number 118 (Wednesday, June 23, 2021)]
[Notices]
[Page 32934]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13121]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--CE21-006: Rigorously Evaluating Programs and
Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Disease,
Disability, and Injury Prevention and Control Special Emphasis Panel
(SEP)--CE21-006: Rigorously Evaluating Programs and Policies to Prevent
Child Sexual Abuse (CSA); July 13-14, 2021, 8:30 a.m.-5:00 p.m., EDT.
The videoconference meeting was published in the Federal Register
on March 29, 2021, Volume 86, Number 58, page 16369.
The meeting is being amended to update the contact person and
should read as follows:
FOR FURTHER INFORMATION CONTACT: Aisha Wilkes, M.P.H., Scientific
Review Officer, National Center for Injury Prevention and Control, CDC,
4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341,
Telephone: (404) 639-6473; Email: [email protected].
The meeting is closed to the public.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-13121 Filed 6-22-21; 8:45 am]
BILLING CODE 4163-18-P
